XML 80 R69.htm IDEA: XBRL DOCUMENT v3.4.0.3
(LOSS) EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Earnings Per Share [Abstract]    
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc. $ (373.7) $ 97.7
Basic weighted-average number of common shares outstanding 344.9 336.8
Diluted effect of stock options, RSUs and other (in shares) 0.0 6.6
Diluted weighted-average number of common shares outstanding 344.9 343.4
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:    
Basic (in usd per share) $ (1.08) $ 0.29
Diluted (in usd per share) $ (1.08) $ 0.28